Galenica AG provided earnings guidance for the year 2019. For the year, the company is raising outlook slightly for the full year 2019. The company expects consolidated net sales of the Galenica Group to grow by 1% to 3%; in the Health & Beauty segment, 4% to 6%; and in the Services segment up to 2%. The company plans to increase adjusted EBIT, excluding the effects of IFRS 19 and IFRS 16, by 5% to 7%. In addition, the company expects EBIT growth of CHF 2 million to CHF 3 million due to IFRS 16.